Clicky

Arcturus Therapeutics Ltd.(ARCT) News

Date Title
May 1 Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for
Apr 29 Arcturus Therapeutics Holdings' (NASDAQ:ARCT) investors will be pleased with their impressive 284% return over the last five years
Apr 25 Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
Mar 28 Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares
Mar 22 Arcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ...
Mar 17 Arcturus Therapeutics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Mar 9 12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
Mar 8 Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript
Mar 8 Q4 2023 Arcturus Therapeutics Holdings Inc Earnings Call
Mar 8 Arcturus Therapeutics Reports Fiscal Year 2023 Financial Results and Pipeline Developments
Mar 7 Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
Mar 7 Arcturus Therapeutics: Q4 Earnings Snapshot
Mar 7 Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
Mar 4 Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why
Dec 21 CSL and Arcturus Therapeutics’ ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster
Dec 8 12 Best Healthcare Stocks For the Long-Term
Dec 4 Arcturus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Dec 1 The Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie
Nov 30 Biotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More
Nov 28 Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults